Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Covic

Showing results (531-540 of 552) with videos related to

Pageof 56
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2021
Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney FailureMaria Jose Soler, Marlies Noordzij, Daniel Abramowicz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS studyJosé Luis Fernández-Martín, Pablo Martínez-Camblor, María Paula Dionisi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2022
Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaborationPriya Vart, Raphaël Duivenvoorden, Casper F M Franssen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 4, 2016
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2)Ken Farrington, Adrian Covic, Fillipo Aucella, et al.
NDT Plus|May 19, 2015
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Raymond Vanholder, Daniel Abramowicz, Jorge B Cannata-Andia, et al.
Kidney International|August 1, 2024
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltrationMatthias Rose, Felix H Fischer, Gregor Liegl, et al.
Hypertension (Dallas, Tex. : 1979)|May 4, 2016
Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure ProfilesGianfranco Parati, Juan Eugenio Ochoa, Grzegorz Bilo, et al.
Hypertension (Dallas, Tex. : 1979)|May 4, 2016
Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and PatternsGianfranco Parati, Juan Eugenio Ochoa, Grzegorz Bilo, et al.
International Urology and Nephrology|March 18, 2016
Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adultsSabine N van der Veer, Wim van Biesen, Pascale Bernaert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeRon T Gansevoort, Mustafa Arici, Thomas Benzing, et al.
Pageof 56

Showing results (531-540 of 552) with videos related to

Sort By:
Pageof 56
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2021
Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney FailureMaria Jose Soler, Marlies Noordzij, Daniel Abramowicz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS studyJosé Luis Fernández-Martín, Pablo Martínez-Camblor, María Paula Dionisi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2022
Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaborationPriya Vart, Raphaël Duivenvoorden, Casper F M Franssen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 4, 2016
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2)Ken Farrington, Adrian Covic, Fillipo Aucella, et al.
NDT Plus|May 19, 2015
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Raymond Vanholder, Daniel Abramowicz, Jorge B Cannata-Andia, et al.
Kidney International|August 1, 2024
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltrationMatthias Rose, Felix H Fischer, Gregor Liegl, et al.
Hypertension (Dallas, Tex. : 1979)|May 4, 2016
Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure ProfilesGianfranco Parati, Juan Eugenio Ochoa, Grzegorz Bilo, et al.
Hypertension (Dallas, Tex. : 1979)|May 4, 2016
Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and PatternsGianfranco Parati, Juan Eugenio Ochoa, Grzegorz Bilo, et al.
International Urology and Nephrology|March 18, 2016
Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adultsSabine N van der Veer, Wim van Biesen, Pascale Bernaert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeRon T Gansevoort, Mustafa Arici, Thomas Benzing, et al.
Pageof 56